Cardiac involvement in granulomatosis with polyangiitis: a magnetic resonance imaging study of 31 consecutive

Grégory Pugnet1,2, Hervé Gouya3, Xavier Puéchal1

  • 1Service de Médecine Interne, Centre National de Référence Vascularites Nécrosantes et Sclérodermie Systémique, Hôpital Cochin, AP-HP, Université Paris Descartes, Paris.

Insights

Cardiac MRI (CMRI) reveals significant heart abnormalities in 61% of granulomatosis with polyangiitis (GPA) patients, often subclinical. Early detection via CMRI is crucial for assessing cardiac lesions and prognosis in GPA.

Area of Science:

  • Cardiology
  • Radiology
  • Rheumatology

Background:

  • Cardiac involvement in granulomatosis with polyangiitis (GPA) is frequently subclinical and underestimated.
  • Assessing cardiac abnormalities in GPA is essential for patient management and prognosis.

Purpose of the Study:

  • To determine the prevalence and patterns of cardiac abnormalities in GPA patients using cardiac MRI (CMRI).
  • To evaluate the utility of CMRI in detecting subclinical cardiac involvement in GPA.

Main Methods:

  • Thirty-one patients with newly diagnosed or relapsing GPA underwent CMRI.
  • CMRI assessed morphology, function, resting perfusion, and late gadolinium enhancement (LGE).

Main Results:

  • 61% of GPA patients showed at least one CMRI abnormality.
  • Left ventricular ejection fraction (LVEF) was impaired in 13%, and regional wall motion abnormalities were seen in 35%.
  • Late gadolinium enhancement (LGE) was detected in 32% of patients, often nodular, and was associated with myocardial early contrast enhancement.

Conclusions:

  • CMRI is a sensitive tool for detecting cardiac involvement in GPA.
  • Non-invasive CMRI provides crucial clinical and prognostic information for GPA patients.
  • Early assessment of cardiac lesions and cumulative damage in GPA is possible with CMRI.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
448
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
714
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
688
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
371
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
550
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
814